Perioperative trastuzumab and pertuzumab in combination with FLOT versus FLOT alone for HER2 positive resectable esophagogastric adenocarcinoma: Petrarca—A phase II trial of the German AIO.Ralf‐Dieter Hofheinz, Salah‐Eddin Al‐Batran, K Borchert et al.|Journal of Clinical Oncology|2017Cited by 12